Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Asset Writedowns and Impairment (2023 - 2025)

Guardian Pharmacy Services' Asset Writedowns and Impairment history spans 3 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 30.94% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $4.6 million, down 28.08%, while the annual FY2025 figure was $4.6 million, 28.08% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $1.5 million at Guardian Pharmacy Services, up from $1.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.1 million in Q4 2024 and bottomed at $896000.0 in Q1 2025.
  • The 3-year median for Asset Writedowns and Impairment is $1.4 million (2023), against an average of $1.4 million.
  • The largest annual shift saw Asset Writedowns and Impairment skyrocketed 56.27% in 2024 before it plummeted 42.0% in 2025.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $1.4 million in 2023, then surged by 56.27% to $2.1 million in 2024, then plummeted by 30.94% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Asset Writedowns and Impairment are $1.5 million (Q4 2025), $1.2 million (Q3 2025), and $1.0 million (Q2 2025).